##plugins.themes.academic_pro.article.sidebar##

Download
pdf
Statistic
Read Counter : 83 Download : 76

##plugins.themes.academic_pro.article.main##

Abstract

COVID-19 (from the English Coronavirus disease 2019) is a new epidemic infectious disease characterized by a relatively high contagiousness and the likelihood of developing life-threatening complications in the form of acute respiratory distress syndrome, acute respiratory and multiple organ failure. a retrospective analysis of the incidence, clinical course and treatment of children with COVID-19 who were treated in a specialized hospital for the treatment of patients with coronavirus infection. We conducted a retrospective analysis of the case histories of 86 children of various ages who were hospitalized with a confirmed diagnosis of a new coronavirus infection COVID-19 in September-November 2020. There were 51 (%) boys, 34 (%) girls. Depending on age, patients were divided into 4 groups: up to 1 year - 7 (%), from 1 year to 6 years - 27 (%), from 7 to 12 years - 26 (%) and over 12 years - 26 (% ). Studies have shown that children with mild COVID-19 were treated on an outpatient basis and therefore were not included in the surveyed group. Children with moderate and severe forms of COVID-19 received inpatient treatment, and in our study, patients with moderate course - 57 (66.3%), and a severe course was noted in 29 (33.7%) children.

Keywords

COVID-19 children cardiovascular system myocardial damage

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite
Bobomuratov T.A, Karimova N.A, Tursunbaev A.K, & Bakirova M.A. (2023). New Coronavirus Infection. Texas Journal of Medical Science, 16, 60–63. https://doi.org/10.62480/tjms.2023.vol16.pp60-63
Crossref
Scopus
Google Scholar
Europe PMC

References

  1. Alimova Kh.P., Rakhmanova D.I., Mardanova Kh.A. and others. Features of the clinical course of coronavirus infection in children // Infection, immunity and pharmacology. - 2021. - No. 4. - P. 34-39.
  2. Zaplatnikov A.L., Svintsitskaya G.I. COVID-19 // GRM.- 2020.- No. 1.- P.1-3.
  3. Ifran O., Tang K., Arin M., Bhutta Z.A. Epidemiology, characteristics and impact on children, adolescents and pregnant women // Pediatric pharmacology.- 2020.- V.17(4).- P.352-359. 4. Sabirov J.R., Khusanov A.M., Shamsutdinova M.I. and others. Health care in the era of a pandemic through the prism of time: international experience and achievements in the fight against COVID-19 // Infection, immunity and pharmacology.- 2021.- No. 4.- P.5-15.
  4. Turabova N.R., Shamsutdinova M.I. Potential scenarios for the development of an immune response to a new type of coronavirus SARS-CoV-2 // Infection, immunity and pharmacology.- 2021.- No. 4.- P. 99-107.
  5. Shamsheva O.V. New coronavirus COVID-19 (SARS-CoV-2) // Children's infections.- 2020.- V.19(1).- P.5-6.
  6. Abduvaliev A.R., Inoyatova F.Kh., Mirkomilov E.M. A method of inhibiting t-helper 2 cells to prevent lung fibrosis that develops as a result of atypical pneumonia in COVID-19 // Proceeding of Global Congress of Contemporary Study- A Multidisciplinary International Scientific Conference Hosted from Pune, M.S. India.-P.182-187. www.econferenceglobe.com
  7. CDC COVID-19 Response Team. Coronavirus disease 2019 in children. United States, February 12-April 2, 2020. MMWR Morb.Mortal Wkly Rep. 2020 Apr 6. http://dx.doi.org/10.15585/mmwr.mm6914e4.
  8. Lu R., Zhao X., Li J, et al. Genomic characterization and epidemiology of 2019 novel cjrjnavirus: Implications for virus origins and receptor binding. // Lancet.- 2020.- Vol.395.- P.565-574.
  9. Paules C.I., Eisinger R.W., Marston H.D., Fauci A.S. What Recent History Has Taught Us About Responding to Emerging Infectious Disease Threats. Ann Intern Med 2017; 167(11): 805–811.
  10. United States Centers for Disease Control and Prevention. Cases in the US. https://coronavirus/2019-ncov/cases-updates/cases-in-uz.html
  11. T.A Bobomuratov, M.A Bakirova, N.A Karimova, M.M Abdullaeva, Features of the Course of Covid-19 in Children of Different Ages (Based on RetrospectiveAnalysis) https://scholar.google.com/citations?view_op=view_citation&hl=ru&user=asb4pUsAAAAJ&citation_for_view=asb4pUsAAAAJ:u-x6o8ySG0sC
  12. Каримова Н.А., Бобамуратов Т.А Евразийский вестник педиатрии 2/9/2021- Cardiovascular system changes in children suffered with covid-19 112-117
  13. Бобомуратов Т.А., Каримова Н.А., Турсунбаев А.К. Вестник Ташкенской Медицинской Академи Течение коронавирусной инфекции у детей стр. 99-103
  14. Бобомуратов Т.А ., Шарипова Д.Ж ., Султанова Н.С - Журнал «Интернаука» № 6 (229), 2022 г Features of the rehabilitation of children with covid-19 стр38-40
  15. Каримова Н.А., Турсунбаев А.К. Academic research in educational sciences 2023/01 Заболевание COVID-19 у детей- стp 53-57
  16. Бобомуратов Т.А., Каримова Н.А., Турсунбаев А.К.- Academic research in educational sciences 2023/01 Oсложнений со стороны сердечно-сосудистой системы у детей, перенесших covid-19 –стр 85-91
  17. Bobomuratov, T. A., Nurmatova, N. F., Sultanova, N. S., Mallaev, S. S., & Fayziev, N. N. (2022). Brestfeeding and Genetic Features of Juvenile Rheumatoid Arthritis. Journal of Pharmaceutical Negative Results, 1983-1988.
  18. Mallaev Sh.Sh, Bobomuratov T.A, Fayziev N.N., Sultanova N.S., Dinmuxammadieva D.R. Genetic Aspects of Juvenile Rheumatoid Arthritis. ISSN (E): 2795 – 7624 VOLUME 10 | JULY 2022. 1-5.
  19. Sh.Sh Mallaev, T.A Bobomuratov, N.S.Sultanova, G.A.Yusupova, A.A.Hoshimov.// Сlinical characteristics and prediction of the outcome of juvenile rheumatoid arthritis in chronotherapy// Chin J Ind Hyg Occup Dis: Vol.39 (No.7). pp. 135-140.